New Key Statistics Module, Z-Score and F-Score
NAS:ADXN Key Ratios
| Market Cap $ M | 8.05 |
| Enterprise Value $ M | 4.38 |
| P/E(ttm) | 9,999.00 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.64 |
| Price/Sales | 13.75 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 1.67 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.31 |
| Beneish M-Score | 34.92 |
| 10-y EBITDA Growth Rate % | 5.00 |
| 5-y EBITDA Growth Rate % | -9.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.30 |
| EV-to-EBITDA | -0.31 |
| PEG | -- |
| Shares Outstanding M | 1.07 |
| Net Margin (%) | 973.87 |
| Operating Margin % | -1,995.86 |
| Pre-tax Margin (%) | -2,283.60 |
| Quick Ratio | 4.59 |
| Current Ratio | 4.59 |
| ROA % (ttm) | 67.59 |
| ROE % (ttm) | 98.53 |
| ROIC % (ttm) | -276.65 |
| Dividend Yield % | -- |
| Altman Z-Score | -39.76 |
ADXN Number of Guru Trades
ADXN Volume of Guru Trades
Gurus Latest Trades with NAS:ADXN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ADXN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Addex Therapeutics Ltd Insider Transactions
No Available Data
News about NAS:ADXN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers